CMM | bioCADDIE Data Discovery Index
Mountain View
biomedical and healthCAre Data Discovery Index Ecosystem
help Advanced Search
Displaying 18 of 18 results for "CMM"
i
  1. EGR1_data Dryad

    DateIssued: 04-06-2017

    Description: Number of EGR1 neurons/mm2 in the NCM, CMM and IC.

  2. Transcription profiling of human common melanocytic nevi, radial and vertical growth phase melanomas, melanoma metastases and dysplastic nevi ArrayExpress

    ID: E-GEOD-12391

    Description: Despite malignant cutaneous melanoma is relatively rare compared to other skin cancers, it is still r...

  3. Melanoma: comparison between common nevi, radial/vertical growth phase melanoma, metastases and dysplastic nevi BioProject

    ID: PRJNA113145

    Keywords: Transcriptome or Gene expression

    Access Type: download

  4. Change in gene expression of a canine melanoma cell line caused by exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) . BioProject

    ID: PRJNA314582

    Keywords: Transcriptome or Gene expression

    Access Type: download

  5. Change in gene expression of a canine melanoma cell line caused by exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) ArrayExpress

    ID: E-GEOD-78988

    Description: pression influenced by NSAIDs treatment. A canine melanoma cell line (Mi/CMM1) was treated by three NSAIDs, piroxicam, carprofen, and robenacoxib, at their half maximal (50%) inhibitory concentrations (116 µM, 779 µM, and 156 µM) for 6 hours. Subsequently, total RNA were extracted and microarray analysis was performed to evaluate change in gene expression caused by NSAIDs treatment. Each condition had three biological replicat...

  6. microbial mat metagenome : Microbial mat metagenome ICM_CMM BioProject

    ID: PRJNA109329

    Keywords: Metagenome

    Access Type: download

  7. alysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma me... ArrayExpress

    ID: E-GEOD-34460

    Description: (miRNA) expression profiles has been reported for cutaneous malignant melanoma (CMM). With regards to a rapidly growing number of newly discovered miR...

  8. Metabolomics guides rational development of a simplified cell culture medium for drug screening against Trypanosoma brucei OmicsDI

    ID: MTBLS49

    Date Released: 05-14-2015

    Description: normally found in blood. Our new minimal medium (CMM) supports in vitro growth equivalent to HMI11, and causes no significant perturbation of metabolite levels for 94% of the detected metabolome (< 3-fold change; a = 0.05). Importantly, improved sensitivity was observed for drug activity studies in whole cell phenotypic screens, and in metabolomics mode of action assays. 400-fold decreases in IC50 were observed for pentamidine and methotrexate, suggesting inhibition of activity by nutrients present in HMI11. CMM is suitable for routine cell culture and offers important advantages for metabolomics studies and drug activity screening....

  9. alysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma me... OmicsDI

    ID: E-GEOD-34460

    Date Released: 11-08-2012

    Description: (miRNA) expression profiles has been reported for cutaneous malignant melanoma (CMM). With regards to a rapidly growing number of newly discovered miR...

  10. Transcription profiling by array of Arabidopsis mutant for seuss and/or aintegumenta ArrayExpress

    ID: E-GEOD-30492

    Description: Arabidopsis thaliana. The carpel margin meristem (CMM) gives rise to the ovule primorida (which begin to form around flower stage 8). We know that the loss of the seuss-3 (seu-3) and aintegumenta-1(ant-1) separately leads to a mild disruption of ovule formation, while the loss of both causes a complete loss of ovule formation....

  11. alysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma me... BioProject

    ID: PRJNA151195

    Keywords: Transcriptome or Gene expression

    Access Type: download

  12. Transcriptomic characterization of a synergistic genetic interaction during carpel margin meristem development in Arabidopsis thaliana BioProject

    ID: PRJNA143511

    Keywords: Transcriptome or Gene expression

    Access Type: download

    dataset.description: Arabidopsis thaliana. The carpel margin meristem (CMM) gives rise to the ovule primorida (which begin to form around flower stage 8). We know that the loss of the seuss-3 (seu-3) and aintegumenta-1(ant-1) separately leads to a mild disruption of ovule formation, while the loss of both causes a complete loss of ovule formation....
  13. Data from: Modeling central metabolism and energy biosynthesis across microbial life Dryad

    DateIssued: 08-10-2016

    Description: gov) to build high quality core metabolic models (CMM) representing accurate energy biosynthesis based on a well studied, phylogenetically diverse set of model organisms. We compare these models to explore the variability of core pathways across all microbial life, and by analyzing the ability of our core models to synthesize ATP and essential biomass precursors, we evaluate the extent to which the core metabolic pathways and functional ETCs are known for all microbes. 6,600 (80%) of our models were found to have some type of aerobic ETC, whereas 5,100 (62%) have an anaerobic ETC, and 1,279 (15%) do not have any ETC. Using our manually curated ETC and energy biosynthesis pathways with no gapfilling at all, we predict accurate ATP yields for nearly 5586 (70%) of the model...

  14. Transcription profiling by array of Arabidopsis mutant for seuss and/or aintegumenta OmicsDI

    ID: E-GEOD-30492

    Date Released: 06-04-2015

    Description: Arabidopsis thaliana. The carpel margin meristem (CMM) gives rise to the ovule primorida (which begin to form around flower stage 8). We know that the loss of the seuss-3 (seu-3) and aintegumenta-1(ant-1) separately leads to a mild disruption of ovule formation, while the loss of both causes a complete loss of ovule formation....

  15. Expression profiling of ccRCC samples treated with anti-VEGF therapies reveals distinct markers BioProject

    ID: PRJNA135853

    Keywords: Transcriptome or Gene expression

    Access Type: download

  16. Expression profiling of ccRCC samples treated with anti-VEGF therapies reveals distinct markers ArrayExpress

    ID: E-GEOD-25698

    Description: Metastatic renal cell carcinoma (mRCC) patients treated with anti-vascular endothelial growth factor (VEGF) therapies demonstrate promising outcomes b...

  17. Change in gene expression of a canine melanoma cell line caused by exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) . OmicsDI

    ID: E-GEOD-78988

    Date Released: 03-11-2016

    Description: pression influenced by NSAIDs treatment. A canine melanoma cell line (Mi/CMM1) was treated by three NSAIDs, piroxicam, carprofen, and robenacoxib, at their half maximal (50%) inhibitory concentrations (116 µM, 779 µM, and 156 µM) for 6 hours. Subsequently, total RNA were extracted and microarray analysis was performed to evaluate change in gene expression caused by NSAIDs treatment. Each condition had three biological replicat...

  18. Study of Melanoma Risk in Australia and the United Kingdom dbGaP

    ID: phs000519.v1.p1

    Description: The results from a small number of melanoma GWAS have been published. Initial studies identified several pigmentation- and nevus-associated loci th...

    Study Types: Case Set


Displaying 18 of 18 results for "CMM"